![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Scinopharm Taiwan, Ltd. Shan-hua Tw, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A leading process R&D and API Manufacturing service provider to the Global Pharmaceutical Industry.
One of their significant offerings is Flumazenil, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-114 - Rev 00
This Chemical Type CEP, issued on March 21, 2013, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1326 associated with this CEP further emphasizes